Pacira BioSciences (PCRX) Prepaid Assets (2010 - 2026)
Pacira BioSciences (PCRX) recorded quarterly Prepaid Assets of $36.8 million in Q1 2026, up 12.75% quarter-over-quarter from $32.6 million in Q4 2025, and up 32.11% on a YoY basis from $27.8 million in Q1 2025.
Pacira BioSciences (PCRX) Prepaid Assets (2010 - 2026) Analysis & Trends
Pacira BioSciences' Prepaid Assets history runs 17 years deep, the most recent figure standing at $36.8 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 32.11% year-over-year to $36.8 million; the TTM figure through Mar 2026 stood at $36.8 million (up 32.11% YoY), while the FY2025 annual figure was $32.6 million, up 48.74% from the prior year.
- Prepaid Assets was $36.8 million for Q1 2026 at Pacira BioSciences, up from $32.6 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $43.5 million in Q3 2025 to a low of $14.4 million in Q3 2022.
- Historically, Prepaid Assets has averaged $23.7 million across 5 years, with a median of $19.8 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets retreated 16.4% in 2023, then jumped 88.25% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $15.2 million in 2022, then jumped by 41.26% to $21.5 million in 2023, then grew by 1.98% to $21.9 million in 2024, then soared by 48.74% to $32.6 million in 2025, then advanced by 12.75% to $36.8 million in 2026.
- The last three Prepaid Assets figures came in at $36.8 million (Q1 2026), $32.6 million (Q4 2025), and $43.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Pacira BioSciences | 935.46 Mn | 733.28 Mn | 140.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.78 Mn |
| Dec 31, 2025 | 32.62 Mn |
| Sep 30, 2025 | 43.47 Mn |
| Jun 30, 2025 | 37.22 Mn |
| Mar 31, 2025 | 27.84 Mn |
| Dec 31, 2024 | 21.93 Mn |
| Sep 30, 2024 | 23.64 Mn |
| Jun 30, 2024 | 19.77 Mn |
| Mar 31, 2024 | 18.80 Mn |
| Dec 31, 2023 | 21.50 Mn |
| Sep 30, 2023 | 18.59 Mn |
| Jun 30, 2023 | 17.35 Mn |
| Mar 31, 2023 | 15.93 Mn |
| Dec 31, 2022 | 15.22 Mn |
| Sep 30, 2022 | 14.42 Mn |
| Jun 30, 2022 | 18.12 Mn |
| Mar 31, 2022 | 19.06 Mn |
| Dec 31, 2021 | 14.77 Mn |
| Sep 30, 2021 | 11.31 Mn |
| Jun 30, 2021 | 12.36 Mn |